(Q43760330)

26 November 2017

title

Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis (English)

1 reference

26 November 2017

Stanislaus R

1

1 reference

26 November 2017

Singh AK

series ordinal

2

1 reference

26 November 2017

Singh I

series ordinal

3

1 reference

26 November 2017

publication date

1 October 2001

1 reference

Journal of Neuroscience Research

26 November 2017

published in

1 reference

26 November 2017

volume

66

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

155-162

1 reference

Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis

26 November 2017

cites work

1 reference

Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis

21 January 2018

1 reference

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

21 January 2018

1 reference

The immunological synapse: a molecular machine controlling T cell activation

21 January 2018

1 reference

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis

21 January 2018

1 reference

Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain

21 January 2018

1 reference

Chronic relapsing experimental allergic encephalomyelitis: morphological sequence of myelin degradation

21 January 2018

1 reference

Cytokines in inflammatory brain lesions: helpful and harmful

21 January 2018

1 reference

Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy

21 January 2018

1 reference

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

21 January 2018

1 reference

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

21 January 2018

1 reference

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

21 January 2018

1 reference

Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma?

21 January 2018

1 reference

Extensive peroxynitrite activity during progressive stages of central nervous system inflammation

21 January 2018

1 reference

Interferons in multiple sclerosis: warnings from experiences

21 January 2018

1 reference

Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Transcription factor NF-kappa B is activated in microglia during experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Statins as a newly recognized type of immunomodulator

21 January 2018

1 reference

1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Immunomodulation: a new role for statins?

21 January 2018

1 reference

Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution

21 January 2018

1 reference

Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin

21 January 2018

1 reference

Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis

21 January 2018

1 reference

Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JNR.1207

1 reference

26 November 2017

1 reference